Fidson Healthcare marks 30 years with N84.2bn revenue surge
Fidson Healthcare Plc is celebrating its 30th anniversary at a pivotal moment, characterised by outstanding financial growth and strategic industry leadership.
In 2024, the company achieved an impressive ¦ 84.2 billion in revenue, marking a 59 per cent increase year-on-year. This strong performance has reinforced Fidson’s position as Nigeria’s largest pharmaceutical company by market capitalisation, which now stands at ¦ 44.64 billion.
The company’s remarkable financial results are supported by a 60 per cent rise in net profit, reaching ¦ 5.78 billion, and a significant growth in earnings per share, from 157 kobo to 252 kobo. These figures reflect efficient financial management and the alignment of stakeholders.
The financial success also benefits shareholders, as the company has proposed an increase in dividends from ¦ 0.60 to ¦ 1.00 per share.
Beyond the financial achievements, Fidson’s strategy focuses on innovation, local manufacturing, and operational excellence. In 2024, the company invested over ¦ 3.7 billion in plant and equipment, underscoring its commitment to reducing reliance on imports and bolstering national health security.
Its WHO-compliant facility in Ogun State has established Fidson as Africa’s leading manufacturer of Large Volume Parenterals (LVPs), producing more than 120 million bottles annually.
With a vast logistics network and 11 distribution depots across Nigeria, Fidson ensures timely access to medicines and broad market reach. This extensive infrastructure, combined with a strong focus on workforce development and employee welfare, supports the company’s resilient organisational culture and sustainable growth.
Fidson’s plans extend beyond Nigeria, with ambitions to expand into African markets and forge strategic partnerships. This broader vision aims to influence public health across the continent. In line with this, the company invested ¦ 248 million in corporate social responsibility (CSR) in 2024, reinforcing its commitment to community and environmental impact.
In summary, Fidson Healthcare is not only celebrating its longevity but also shaping the future of pharmaceutical excellence in Nigeria and beyond, through innovation, local empowerment, and strategic growth.
